- Home
- AZZ vs RDY Comparison
AZZ vs RDY Comparison
Compare AZZ & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZZ
- RDY
- Stock Information
- Founded
- AZZ 1956
- RDY 1984
- Country
- AZZ United States
- RDY India
- Employees
- AZZ N/A
- RDY N/A
- Industry
- AZZ Industrial Specialties
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- AZZ Industrials
- RDY Health Care
- Exchange
- AZZ Nasdaq
- RDY Nasdaq
- Market Cap
- AZZ 2.5B
- RDY 2.5B
- IPO Year
- AZZ N/A
- RDY N/A
- Fundamental
- Price
- AZZ $95.16
- RDY $13.35
- Analyst Decision
- AZZ Buy
- RDY Buy
- Analyst Count
- AZZ 7
- RDY 1
- Target Price
- AZZ $100.67
- RDY $17.00
- AVG Volume (30 Days)
- AZZ 238.5K
- RDY 1.8M
- Earning Date
- AZZ 01-07-2025
- RDY 01-23-2025
- Dividend Yield
- AZZ 0.71%
- RDY 3.60%
- EPS Growth
- AZZ N/A
- RDY 2.68
- EPS
- AZZ 1.28
- RDY 0.75
- Revenue
- AZZ $1,592,438,000.00
- RDY $3,637,607,642.00
- Revenue This Year
- AZZ $4.84
- RDY $17.23
- Revenue Next Year
- AZZ $5.21
- RDY $9.20
- P/E Ratio
- AZZ $76.28
- RDY $17.68
- Revenue Growth
- AZZ 5.63
- RDY 14.74
- 52 Week Low
- AZZ $69.59
- RDY $13.16
- 52 Week High
- AZZ $99.49
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- AZZ 57.20
- RDY 33.41
- Support Level
- AZZ $96.47
- RDY $13.16
- Resistance Level
- AZZ $99.49
- RDY $13.46
- Average True Range (ATR)
- AZZ 2.89
- RDY 0.15
- MACD
- AZZ 0.21
- RDY -0.01
- Stochastic Oscillator
- AZZ 74.30
- RDY 21.02
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. In its Metal Coatings segment, the company offers metal finishing services to protect against corrosion, such as hot dip galvanizing, spin galvanizing, powder coating, anodizing, and plating. The Precoat Metals Segment offers aesthetic and corrosion-resistant coatings for steel and aluminum coils.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.